2001
DOI: 10.1046/j.1198-743x.2001.00326.x
|View full text |Cite
|
Sign up to set email alerts
|

A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI–003 study)

Abstract: Nosocomial UTI accounts for an important proportion of the workload in microbiology laboratories. A consensus on the practice and interpretation of urine cultures in Europe is needed. The levels and patterns of resistance of UTI pathogens must be a serious cause for concern and a clear reason for stricter guidelines and regulations in antimicrobial policy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
71
1
9

Year Published

2004
2004
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 156 publications
(86 citation statements)
references
References 35 publications
5
71
1
9
Order By: Relevance
“…1,11 In contrast to community-acquired UTI, in which Escherichia coli is the single most common pathogen, the aetiological diversity (with no particularly predominant uropathogens) in CA-UTI leads to difficulty in predicting aetiological micro-organisms. 4,12 Recent reviews on nosocomial UTI have suggested that patients should be empirically treated with a cephalosporin or a penicillin/b-lactamase inhibitor with antipseudomonal activity, a carbapenem, a fluoroquinolone, aztreonam, or an aminoglycoside. 11,13 All of these regimens were mainly targeted at Gram-negative rod or nonfermenter infections.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,11 In contrast to community-acquired UTI, in which Escherichia coli is the single most common pathogen, the aetiological diversity (with no particularly predominant uropathogens) in CA-UTI leads to difficulty in predicting aetiological micro-organisms. 4,12 Recent reviews on nosocomial UTI have suggested that patients should be empirically treated with a cephalosporin or a penicillin/b-lactamase inhibitor with antipseudomonal activity, a carbapenem, a fluoroquinolone, aztreonam, or an aminoglycoside. 11,13 All of these regimens were mainly targeted at Gram-negative rod or nonfermenter infections.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to community-acquired, uncomplicated UTI, a wide variety of micro-organisms have been isolated from patients with CA-UTI. 3,4 In addition, because uropathogens in CA-UTI tend to show high rates of antibiotic resistance, the selection of appropriate empirical antibiotic treatment may be difficult. 5,6 Until microbiological results are available, appropriate selection of antibiotics for CA-UTI depends on known susceptibility patterns of suspected bacterial uropathogens, with third-generation cephalosporins or fluoroquinolones being used for enteric Gram-negative rods, ceftazidime for nonfermenters, ampicillin or vancomycin for enterococci, and methicillin for staphylococci.…”
Section: Introductionmentioning
confidence: 99%
“…Kısa süreli (30 gün altında) sonda uygulanma oranı %90.8 olarak saptanmıştır. Sonda uygulanma süresi vakaların %44.8'inde 1-7 gün, %46'sındaysa 8-30 gündür (5).…”
Section: Epidemiyolojiunclassified
“…National and international surveillance programmes are necessary to monitor the level of antimicrobial resistance [2]. According to the data obtained in a questionnaire from 228 hospitals in 29 European countries, the most frequent pathogen was identified as E.coli (35.6%), where 54.8% of isolates were resistant to ampicillin, 28% to co-trimoxazole and 9% to ciprofloxacin [3]. Alarmingly, significant ampicillin resistance (72.6%), cotrimoxazole resistance (77.9%) and norfloxacin resistance (78.4%) in E.coli strains were also reported [4].…”
Section: Introductionmentioning
confidence: 99%